Trade Bristol Myers ^BMY

Bristol Myers Squibb (BMY) Returns To US$7.1b Trailing Profit Challenging Bearish Narratives

What Catalysts Are Rewriting The Story For Bristol Myers Squibb (BMY)?

Bristol Myers Squibb Company $BMY Shares Sold by Wells Trecaso Financial Group LLC

Bristol Myers Squibb (NYSE:BMY) Given New $64.00 Price Target at Citigroup - Daily Political

HORAN Wealth LLC Makes New $454,000 Investment in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Q4 Earnings Call Highlights

Bristol Myers Squibb (NYSE:BMY) Releases Quarterly Earnings Results, Misses Expectations By $0.39 EPS - Markets Daily

Bristol Myers Squibb (NYSE:BMY) Announces Quarterly Earnings Results, Misses Estimates By $0.39 EPS

Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade

Bristol's Portfolio of Newer Therapies and Strong Late-Stage Pipeline Support a Wide Moat | Morningstar

Trump set to unveil website for low-cost prescription drugs | Fox Business

TrumpRx, the prescription drug website, set to launch - Yahoo News Canada

Bristol Myers forecasts upbeat 2026, expecting Eliquis price cut to pay off

Bristol Myers Squibb Q4 25 Earnings Conference Call At 8:00 AM ET

Bristol Myers Squibb Company $BMY Shares Bought by Ashton Thomas Private Wealth LLC

Bristol-Myers Squibb Guides FY26 Above Estimates - Update

Bristol Myers Squibb Co. Reveals Rise In Q4 Profit

Bristol Myers Squibb (NYSE:BMY) Issues FY 2026 Earnings Guidance - Daily Political

Homestead Advisers Corp Sells 539,800 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Bristol-Myers Squibb Expands RNA And Cell Therapy Pipeline With New Deals

NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy

10 Best Blue-Chip Stocks to Invest in for the Long Term | Morningstar Europe

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

Bristol-Myers Weighs RNA Expansion Against Sprycel Generic Pressures

Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead

Bristol Myers Squibb Company $BMY Shares Sold by Pettee Investors Inc.

Peterson Wealth Services Buys 41,762 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Principal Financial Group Inc.

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Regeneron (REGN) | Markets Insider

TD Waterhouse Canada Inc. Lowers Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol-Myers Squibb Company (BMY): A Bull Case Theory

TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Lupin launches generic cancer drug in U.S.

Convergence Investment Partners LLC Raises Stake in Bristol Myers Squibb Company $BMY

Mutual Advisors LLC Increases Holdings in Bristol Myers Squibb Company $BMY

Piper Sandler Raises Bristol Myers (BMY) PT to $66 Citing Pipeline Visibility

Here are the 7 big things we're focused on in the stock market this week

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

Y Intercept Hong Kong Ltd Sells 170,707 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Mediolanum International Funds Ltd

Bristol-Myers Squibb Cancer And AI Deals Put Valuation In Focus

Summit Global Investments Acquires New Position in Bristol Myers Squibb Company $BMY - Daily Political

Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C

Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026

IgG4-Related Disease Market Size is Projected to grow at a CAGR of 34.60% by 2034, estimates DelveInsight

Bristol Myers Moves Supreme Court to Stop Zydus from Selling Biosimilar Cancer Drug - The Economic Times

Bristol Myers moves SC to stop Zydus from selling biosimilar cancer drug - The Economic Times

Ruffer LLP Invests $6.84 Million in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Stock Position Increased by Mirae Asset Global Investments Co. Ltd.

Truist Financial Corp Has $58.25 Million Stake in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Position Trimmed by Truist Financial Corp

Bank of New York Mellon Corp Cuts Stake in Bristol Myers Squibb Company $BMY

AustralianSuper Pty Ltd Lowers Stock Holdings in Bristol Myers Squibb Company $BMY

Is Bristol Myers Squibb (BMY) Pricing Reflect Its Fundamentals After A Steady Share Performance

Bristol Myers Squibb (BMY) to Release Quarterly Earnings on Thursday

Bristol Myers Squibb (BMY), Microsoft (MSFT) Partner to Enhance Early Lung Cancer Detection Through AI

10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Cambiar Investors LLC Trims Stake in Bristol Myers Squibb Company $BMY - Markets Daily

Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy

Phoenix Financial Ltd. Raises Stock Position in Bristol Myers Squibb Company $BMY

Vanguard Personalized Indexing Management LLC Reduces Stock Position in Bristol Myers Squibb Company $BMY

Mutual of America Capital Management LLC Lowers Position in Bristol Myers Squibb Company $BMY - Markets Daily

Syngene Presses Ahead With Capex And Capacity Build As Biologics Impact Weighs On Q3

Belpointe Asset Management LLC Purchases 30,833 Shares of Bristol Myers Squibb Company $BMY

Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight

Patten & Patten Inc. TN Decreases Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Patten & Patten Inc. TN - Stock Observer

Lbp Am Sa Cuts Stake in Bristol Myers Squibb Company $BMY - Daily Political

MBM Wealth Consultants LLC Takes Position in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Sector Gamma AS - Markets Daily

Trek Financial LLC Invests $1.49 Million in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by Quilter Plc

Resona Asset Management Co. Ltd. Sells 46,004 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Resona Asset Management Co. Ltd. Lowers Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by UniSuper Management Pty Ltd

Bristol Myers Squibb Company $BMY Shares Acquired by Mitsubishi UFJ Trust & Banking Corp

iA Global Asset Management Inc. Boosts Stake in Bristol Myers Squibb Company $BMY

Strs Ohio Decreases Holdings in Bristol Myers Squibb Company $BMY

Camzyos Trial Win and Microsoft AI Lung Program Might Change The Case For Investing In BMY

A Look At Bristol Myers Squibb (BMY) Valuation After New Microsoft AI Pact And Camzyos Trial Results

Teacher Retirement System of Texas Increases Position in Bristol Myers Squibb Company $BMY - Markets Daily

Zydus Lifesciences launches world's first nivolumab biosimilar in India, boosting cancer treatment affordability - The Economic Times

Syngene Intl looks to diversify revenue as single biologics programme weighs on performance

Teacher Retirement System of Texas Acquires 168,780 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Did AI Lung Imaging And New HCM Data Just Shift Bristol Myers Squibb's (BMY) Investment Narrative?

Zydus Rolls Out Biosimilar of 'Nivolumab' Cancer Drug - The Economic Times

Microsoft Pushes Applied AI Deeper Into Retail And Healthcare Workflows

Will DJT skyrocket in 2026: Is DJT stock a good long-term investment?

XRP price analysis: XRP/USD slides, what’s going on with Ripple?

Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?

Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

AI stocks and investment opportunities: What are the best ai stocks to invest in?

Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Bitcoin price prediction: Will bitcoin outperform stocks and gold in 2026?

AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

Best Retail Stocks to Buy: Amazon (AMZN) stock, WMT stock, Home Depot

ETF trading for beginners: What’s the best S&P 500 ETF to invest in 2026?

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Market Movers: Fed Rate Decision & Key Economic Data in Focus Next Week

Central Bank Rate Decisions & Market Volatility Outlook: What to Expect

Clear Street Prepares for IPO Amid Crypto Treasury Model Concerns

Crypto Market Analysis and Regulatory Updates: December 6, 2024

Bitcoin Treasury Firms Face 'Darwinian Phase' Amid Market Shift